Literature DB >> 6193521

Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility.

S M Goyert, J Silver.   

Abstract

HLA-DS molecules, the human homologs of murine I-A molecules, were analyzed and compared to DR molecules by two-dimensional gel analysis. These analyses allowed us to define six forms of DS molecules, suggesting that DS molecules were as polymorphic as DR molecules. The supertypic specificities, MT1 and MB3 were localized to DS molecules, whereas MT3 appeared to represent a crossreactive determinant present on products of two different loci encoding Ia-like molecules in man, a DS4 molecule and a DR7-like molecule. These studies also revealed that MT1 molecules isolated from DR1 and DR2 cell lines were different, as were MB3 molecules isolated from DR4 and DR5 cell lines. Extensive crossreactions between DR and DS molecules were observed by using several monoclonal antibodies. This sharing of epitopes between products of different loci for human Ia molecules has important functional implications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193521      PMCID: PMC384330          DOI: 10.1073/pnas.80.18.5719

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  The human Ia system.

Authors:  R J Winchester; H G Kunkel
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Identification of an HLA-DR-associated system of B-cell alloantigens.

Authors:  R J Duquesnoy; M Marrari; K Annen
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

3.  Structural studies of murine I-E and human DR antigens.

Authors:  J Silver; L E Walker; R A Reisfeld; M A Pellegrino; S Ferrone
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

4.  Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO.

Authors:  S Shaw; P Kavathas; M S Pollack; D Charmot; C Mawas
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

5.  Isolation of I-A subregion-like molecules from subhuman primates and man.

Authors:  S M Goyert; J Silver
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

6.  Murine Ia and human DR antigens: homology of amino-terminal sequences.

Authors:  J P Allison; L E Walker; W A Russell; M A Pellegrino; S Ferrone; R A Reisfeld; J A Frelinger; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.

Authors:  D A Shackelford; D L Mann; J J van Rood; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

8.  Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus.

Authors:  N Tanigaki; R Tosi; D Pressman; G B Ferrara
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Dw/LD-related molecular polymorphism of DR4 beta-chains.

Authors:  J P Groner; A J Watson; F H Bach
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

10.  Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules.

Authors:  S M Goyert; J E Shively; J Silver
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  36 in total

Review 1.  Interisotypic alpha- and beta-chain assembly as a source of HLA class-II diversity.

Authors:  D J Charron; P Hermans; V Lotteau; B Merlu; F Amesland; P Turmel; L Tevton
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5).

Authors:  P Loiseau; P Lehn; F Dautry; V Lepage; J Colombani; D Cohen; J Dausset; L Degos
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Functional characterization of infiltrating T lymphocytes in human hepatic allografts.

Authors:  J J Fung; A Zeevi; T E Starzl; J Demetris; S Iwatsuki; R J Duquesnoy
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

4.  Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion.

Authors:  R C Giles; R DeMars; C C Chang; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Detection of a novel HLA-DQ specificity: serological and immunochemical analyses by a monoclonal antibody.

Authors:  N Ishikawa; H Kojima; T Nakayama; H Kunikane; S Hawkin; Y Fukasawa; H Ikeda; K Ogasawara; M Kasahara; Y Tajima
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.

Authors:  S Rosen-Bronson; A H Johnson; R J Hartzman; D D Eckels
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

7.  A human cytotoxic lymphocyte subdividing the DQ1 antigen.

Authors:  J D Fraser; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Molecular diversity of HLA-DQ. DQ alpha and beta chain isoelectric point differences and their relation to serologically defined HLA-DQ allospecificities.

Authors:  R E Bontrop; E J Baas; N Otting; G M Schreuder; M J Giphart
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

9.  Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications.

Authors:  J Moriuchi; T Moriuchi; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.

Authors:  B S Nepom; G T Nepom; E Mickelson; P Antonelli; J A Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.